Cargando…
Antidepressants are a rational complementary therapy for the treatment of Alzheimer's disease
There is a high prevalence rate (30-50%) of Alzheimer's disease (AD) and depression comorbidity. Depression can be a risk factor for the development of AD or it can be developed secondary to the neurodegenerative process. There are numerous documented diagnosis and treatment challenges for the...
Autores principales: | Aboukhatwa, Marwa, Dosanjh, Laura, Luo, Yuan |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2845130/ https://www.ncbi.nlm.nih.gov/pubmed/20226030 http://dx.doi.org/10.1186/1750-1326-5-10 |
Ejemplares similares
-
Antidepressant stimulation of CDP-diacylglycerol synthesis does not require monoamine reuptake inhibition
por: Aboukhatwa, Marwa A, et al.
Publicado: (2010) -
Rational antidepressant use
por: Dunleavy, Daniel
Publicado: (2018) -
Practical Management for Use of Eculizumab in the Treatment of Severe, Refractory, Non-Thymomatous, AChR + Generalized Myasthenia Gravis: A Systematic Review
por: Waheed, Waqar, et al.
Publicado: (2022) -
Memantine and Cholinesterase Inhibitors: Complementary Mechanisms in the Treatment of Alzheimer’s Disease
por: Parsons, Chris G., et al.
Publicado: (2013) -
Antidepressants in Alzheimer’s Disease: A Focus on the Role of Mirtazapine
por: Correia, Ana Salomé, et al.
Publicado: (2021)